- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04118569
Personalized Experiences to Inform Improved Communication for Patients With Life Limiting Illness
April 6, 2023 updated by: University of Colorado, Denver
Disparities in palliative care for patients with serious illness exist because of gaps in knowledge around patient centered psychological, social, and spiritual palliative care interventions.
Patient-centered palliative care communication interventions must be informed by the perspectives of patients who are living each day with their serious illness.
Yet, there is a lack of research about how to efficiently and effectively integrate the patient's narrative into the electronic health record (EHR).
The central hypothesis of this proposal is that the implementation of a patient-centered narrative intervention with patients with serious illness will result in improved patient-nurse communication and improved patient psychosocial and spiritual well-being.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The overall goal during this study will be to conduct a small scale pilot study with 80 hospitalized patients and 80 acute care nurses.
Specific Aim 1 will establish acceptability, feasibility, and potential effect size of the patient-centered narrative intervention for hospitalized patients with serious illness.
For specific aim 2, the investigators will compare the effects of the narrative intervention to usual care for the primary outcome of patient's perception of quality of communication and patient's psychosocial and spiritual well-being.
For specific aim 3, the investigators will conduct usability testing, applying a user-task-system-environment evaluation process to determine essential requirements for integration and use of the patient-centered story into the EHR, from the perspective of an important end user: the acute-care bedside nurse.
These results will support future R01 applications for testing/tailoring patient-centered narrative interventions to improve QoL for patients living with serious illness.
Study Type
Interventional
Enrollment (Actual)
51
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 18 years or older.
- Has ability to read English.
- Capable of giving informed consent.
- Has diagnosis of at least one serious illness. For this study, the eligible diagnoses include: 1) New York Heart Class III or IV heart failure and/or 2) dialysis-dependent renal failure
Exclusion Criteria:
- None.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Narrative Intervention Group
Patients in the narrative intervention group will participate in an interview and the resulting narrative will be uploaded to the electronic medical record.
This group will also complete outcome measures (questionnaires) and exit interview.
|
Research staff conducts an open-ended, audio-recorded interview with the patient about their illness and how this illness has affected their psycho-social-spiritual well-being.
The investigators will use the interview transcription to create a meta-narrative, which is then uploaded to the electronic medical record and the patient's primary nurse is notified that it is available to read.
|
|
No Intervention: Usual Care Group
Patients in the usual care group will complete outcome measures (questionnaires) and exit interview only.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Quality of Communication: QOC (Quality of Communication) survey
Time Frame: Time 1= Baseline, Time 2= 24-48 hours after baseline, Time 3- 24-48 hours after Time 2
|
The QOC survey assesses patients' perceptions of the quality of communication with nurses.
The QOC was initially developed from qualitative interviews and focus groups with diverse set of patients, families and providers.
The QOC has 19 items, with scores ranging from 0 (worst) to 10 (best).
Internal consistency reliability and construct validity of the QOC has been established across several illness groups, and the QOC survey's responsiveness to communication interventions has been demonstrated by changes in pre- and post-intervention scores.
|
Time 1= Baseline, Time 2= 24-48 hours after baseline, Time 3- 24-48 hours after Time 2
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Patient-Reported Outcomes Measurement Information System (PROMIS)- 29 Profile
Time Frame: Time 1= Baseline, Time 2= 24-48 hours after baseline, Time 3- 24-48 hours after Time 2
|
PROMIS- 29 profile v2.0 form (29 items), which assesses physiological, social, and psychological outcomes.
These biopsychosocial domains include physical function, anxiety, depression, fatigue, sleep, ability to participate in social roles/activities, pain interference and intensity.
The questions are ranked on a 5-point Likert Scale.
There is also one 11-point rating scale for pain intensity.
High scores represent more of the domain being measured.
Thus, on symptom-oriented domains of PROMIS-29 (anxiety, depression, fatigue, pain interference, and sleep disturbance), higher scores represent worse symptomatology.
On the function-oriented domains (physical functioning and social role) higher scores represent better functioning.
For example, a high sleep disturbance score indicates high levels of sleep disturbance; a high physical functioning score indicates better physical function.
|
Time 1= Baseline, Time 2= 24-48 hours after baseline, Time 3- 24-48 hours after Time 2
|
|
Change in Patient-Reported Outcome Measurement Information-System (PROMIS)- Psychosocial Illness Impact
Time Frame: Time 1= Baseline, Time 2= 24-48 hours after baseline, Time 3- 24-48 hours after Time 2
|
The PROMIS positive item bank measure (8 items) assesses positive psychosocial outcomes of illness.The PROMIS negative item bank measure (8 items) assesses the direct negative psychosocial effect of illness, distinct from general emotional distress.
The item bank instructs participants to think about how their illness has affected them.
The item bank uses the time frames: before your illness" and "since your illness".
For adults, each question has five response options ranging in value from two to five.
To find the total raw score for a short form with all questions answered, sum the values of the response to each question, range 16-40.
A higher PROMIS T-score represents more of the concept being measured.
For positively-worded concepts like Psychosocial Illness Impact-Positive, a T-score of 60 is one standard deviation (SD) better than average.
By comparison, a Psychosocial Illness Impact-Positive T-score of 40 is one SD worse than average.
|
Time 1= Baseline, Time 2= 24-48 hours after baseline, Time 3- 24-48 hours after Time 2
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2019
Primary Completion (Actual)
June 22, 2022
Study Completion (Actual)
June 22, 2022
Study Registration Dates
First Submitted
October 3, 2019
First Submitted That Met QC Criteria
October 7, 2019
First Posted (Actual)
October 8, 2019
Study Record Updates
Last Update Posted (Estimate)
April 10, 2023
Last Update Submitted That Met QC Criteria
April 6, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-1874
- 4R00NR016686-03 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The final data set will include de-identified self-reported demographic and behavioral data from self-report, questionnaires, and interviews.
The de-identified data and associated documentation will be made available to the community of scientists interested in palliative care as described in "access criteria."
Additionally, aggregate, de-identified results will be submitted to ClinicalTrials.gov
no later than one year after the trial's primary completion date.
IPD Sharing Time Frame
Up to ten years
IPD Sharing Access Criteria
The data and associated documentation will be made available to users only under a data-sharing agreement that provides for (a) a commitment to using the data only for research purposes and not to identify any individual patient; (b) a commitment to securing the data using appropriate computer technology; and (c) a commitment to destroying or returning the data after analyses are completed.
Such a data-use agreement will be executed through the PI.
The database of demographic and patient reported outcomes and de-identified transcripts will only be accessed via the investigator's secure website or shared via encrypted delivery.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
Clinical Trials on Narrative Intervention
-
Riphah International UniversityRecruiting
-
Sarah SchlegelHarvard Catalyst Pilot GrantRecruitingHypospadias | DSDUnited States
-
Catalan Institute of HealthRecruitingOveruse SyndromeSpain
-
University of ChicagoPlanned Parenthood Federation of AmericaCompleted
-
George Washington UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingInjury PreventionUnited States
-
Alexandria UniversityCompletedDevelopmental Language Disorder | Hearing Impaired ChildrenEgypt
-
Chinese University of Hong KongRecruiting
-
Peking UniversityCompleted
-
University of KonstanzCompletedPosttraumatic Stress Disorder | Mental Health Issue | Family DynamicsBurundi
-
University of CoimbraActive, not recruitingAutism Spectrum DisorderPortugal